HIPRA was the main sponsor for the fourth consecutive year at the RUVASA conference, held in the Western Cape on the 8 – 10 June 2015. The conference was well attended, by more than 160 veterinarians (Large and Small ruminant) from South Africa and neighbouring countries. The proceedings covered a vast array of topics and HIPRA was well represented by local and international speakers, each addressing important aspects of disease control and prevention. Dr Peter Orpin (United Kingdom) presented his paper on the “Practical approaches in BVD and IBR control from a UK perspective” and Dr Inge-Marie Petzer (South Africa) presented her findings from a field trial conducted to investigate the effectiveness of a Mastitis vaccine (STARTVAC®) in a Staphylococcus aureus positive herd as well as a computer programme for predicting the economic outcomes determined by different levels of mastitis prevalence, management and prevention. Dr Grant van Lelyveld (HIPRA South Africa) presented a short scientific paper on STARTCHECK® as a valuable diagnostic tool that shows the importance of Staph. aureus, E. coli, CNS and Coliform mastitis pathogens (data from 301 Milk samples) in South African dairy farms, Dr Vincent Robles (HIPRA Spain) presented a short scientific paper on the protection provided by HIPRABOVIS® vaccines: against foetal infection by BVD, abortions and risk of PI’s and Dr Santiago Casademunt Garre (HIPRA Spain) presented a short scientific paper on IBR, BVDV and BRSV determination by the innovative tool BOVIRESP FTA®.
In addition to the technical presentations on the HIPRA products and diagnostic tools, HIPRA had an interactive stand where the attending veterinarians could speak to the HIPRA team and guest speakers Dr Peter Orpin and Dr Inge-Marie Petzer. During the conference HIPRA held a competition questionnaire at the stand and the lucky winner was Dr Gavin King from Underberg Veterinary clinic, KZN.
By participating in this conference, HIPRA has reinforced its commitment to being the Reference in Prevention for Animal Health and the leaders in Bovine Respiratory Disease (BRD) and Mastitis prevention. Reiterating that HIPRABOVIS®4 is ideally suited due to its versatility within a farm by providing herd and individual immunity and that STARTVAC® is ideally suited to control Mastitis in Southern Africa, by providing an immunity against Staph. aureus, E. coli, CNS and coliforms.
For more information about this news item, contact:
Dr Grant van Lelyveld (012) 348 1506 or email@example.com